Literature DB >> 21080849

Hazards with electrocautery-induced decomposition of fatty acids--in view of lipid embolization.

Karin Engström1, Karl Gunnar Engström.   

Abstract

OBJECTIVES: Electrocautery is an appreciated surgical tool, which however, generates immense heat and fat-tissue melting. In cardiac surgery, liquefied fat collects on the surface of blood in the pericardial cavity and becomes aspirated by the heart-lung machine for aortic recycling. Deposits seen in the brain microcirculation after surgery are caused by lipid embolism. This study investigates lipid chemistry, whether heat from electrocautery generates fatty-acid fragmentation and decomposition.
DESIGN: Pericardial fat tissue was sampled from cardiac-surgery patients and from piglets. The human tissue was exposed to electrocautery, or to fixed temperatures in an in vitro model. Fatty-acid decomposition was explored by solid-phase microextraction gas chromatography and the distribution of fatty acids was measured.
RESULTS: Fatty-acid decomposition demonstrated a temperature-effect relationship (p = 0.007). At 350°C the proportion of polyunsaturated fatty acids became heavily reduced or were abolished (p = 0.016). Electrocautery resulted in similar changes.
CONCLUSIONS: Electrocautery induces a profound fatty-acid fragmentation to form short-chained compounds. The chemical and toxic nature of these compounds remains to be determined, including their clinical implications at blood recycling in cardiac surgery.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21080849     DOI: 10.3109/14017431.2010.491553

Source DB:  PubMed          Journal:  Scand Cardiovasc J        ISSN: 1401-7431            Impact factor:   1.589


  1 in total

1.  Reducing the risk of postoperative pancreatic fistula in radical gastrectomy: pre-assessment with computed tomography for the diagnosis of pancreatic steatosis.

Authors:  Nao Kobayashi; Hisashi Shinohara; Shusuke Haruta; Harushi Udagawa; Masaki Ueno
Journal:  Langenbecks Arch Surg       Date:  2021-09-24       Impact factor: 3.445

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.